We are live on ! Find out more
DRTX

DURATA THERAPEUTICS INC COM STK (DE)
DRTX

Delisted

DRTX was delisted on the 17th of November, 2014.

Back to rankings

74 hedge funds and large institutions have $229M invested in DURATA THERAPEUTICS INC COM STK (DE) in 2014 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 10

136% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 11

33% more capital invested

Capital invested by funds: $172M → $229M (+$56.8M)

25% more funds holding

Funds holding: 59 → 74 (+15)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

57% less call options, than puts

Call options by funds: $2.41M | Put options by funds: $5.55M

Holders
74
Holders Change
+15
Holders Change %
+25.42%
% of All Funds
2.13%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
26
Increased
30
Reduced
10
Closed
11
Calls
$2.41M
Puts
$5.55M
Net Calls
-$3.14M
Net Calls Change
-$3.2M

Top Buyers

Rank Fund Capital Flow
1
O
OppenheimerFunds
New York
+$14.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.9M
3
GIM
Granahan Investment Management
Massachusetts
+$2.43M
4
Allianz Asset Management
Allianz Asset Management
Germany
+$1.52M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.08M

Top Sellers

Rank Fund Capital Flow
1
AC
Aisling Capital
New York
-$14.9M
2
DCM
Discovery Capital Management
Connecticut
-$12.6M
3
SC
Sophrosyne Capital
New York
-$1.42M
4
Millennium Management
Millennium Management
New York
-$852K
5
SIM
SSI Investment Management
California
-$459K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$216K +$16.2K +1,088 +9%
MLICM
52
Metropolitan Life Insurance Company (MetLife)
New York
$209K +$7.12K +478 +4%
CS
53
Credit Suisse
Switzerland
$188K -$107K -7,178 -39%
Manulife (Manufacturers Life Insurance)
54
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$174K -$13.2K -886 -8%
AllianceBernstein
55
AllianceBernstein
Tennessee
$170K +$147K +9,859 +6,992%
LWA
56
Lenox Wealth Advisors
New York
$129K – – –
Goldman Sachs
57
Goldman Sachs
New York
$114K +$99.5K +6,685 New
BA
58
BlackRock Advisors
Delaware
$111K -$2.52K -169 -3%
MTIP
59
Magee Thomson Investment Partners
California
$86K +$75.5K +5,073 New
NFG
60
Next Financial Group
Texas
$83K +$87.6K +5,884 New
QT
61
Quantbot Technologies
New York
$54K +$47.6K +3,200 New
VFA
62
Virtus Fund Advisers
Connecticut
$23K +$19.7K +1,325 New
LTFS
63
Ladenburg Thalmann Financial Services
Florida
$17K – – –
ClearBridge Investments
64
ClearBridge Investments
New York
$12K +$298 +20 +3%
Creative Planning
65
Creative Planning
Kansas
$9K +$7.44K +500 New
BlackRock
66
BlackRock
New York
$7K +$6.4K +430 New
Bank of Montreal
67
Bank of Montreal
Ontario, Canada
$6K +$4.91K +330 New
TWA
68
TCI Wealth Advisors
Arizona
$5K +$4.47K +300 New
Barclays
69
Barclays
United Kingdom
$4K -$1.46K -98 -27%
Citigroup
70
Citigroup
New York
$3K -$19.5K -1,308 -90%
Deutsche Bank
71
Deutsche Bank
Germany
$1K -$215K -14,417 -99%
Ameriprise
72
Ameriprise
Minnesota
$1K +$744 +50 New
Canada Life
73
Canada Life
Manitoba, Canada
$1K +$968 +65 New
BNP Paribas Financial Markets
74
BNP Paribas Financial Markets
France
$630 +$551 +37 New
DCM
75
Discovery Capital Management
Connecticut
– -$12.6M -939,182 Closed
1 2
3
4

DRTX Hedge Fund Activity: Q2 2014 in Review

74 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in DURATA THERAPEUTICS INC COM STK (DE) (DRTX) for Q2 2014, worth a combined $229M — up 33% from $172M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new DRTX positions and 11 closed out — a net gain of 15 holders — while 30 added to existing stakes and 10 trimmed.

The largest buyer was OppenheimerFunds, opening a new position worth an estimated $14.9M. The largest seller was Aisling Capital, cutting an estimated $14.9M.

  • 74 institutional investors held DURATA THERAPEUTICS INC COM STK (DE) (DRTX) as of Q2 2014, up from 59 in Q1 2014.
  • Funds reported $229M of DURATA THERAPEUTICS INC COM STK (DE) stock for Q2 2014, up 33% quarter-over-quarter.
  • 26 funds opened new DURATA THERAPEUTICS INC COM STK (DE) positions in Q2 2014 and 11 closed out, a net change of +15 holders.
  • The largest DURATA THERAPEUTICS INC COM STK (DE) buyer in Q2 2014 was OppenheimerFunds, an estimated $14.9M added.
  • The largest DURATA THERAPEUTICS INC COM STK (DE) seller in Q2 2014 was Aisling Capital, an estimated $14.9M sold.

Based on aggregated 13F filings for Q2 2014.